This week an advisory panel to the Food and Drug Administration voted unanimously to recommend the approval of the first-ever rapid, over-the-counter, completely in-home HIV test. Though the FDA has approved other HIV test kits designed for at-home use in the past, those tests require a blood sample that must be sent in to a laboratory for development. The newly considered test kit – called the OraQuick In-Home HIV Test – simply requires a mouth swab and a 20-minute wait for results.
It’s estimated that approximately one-fifth of the 1.2 million HIV carriers in the United States are unaware of their infection, and advocates of OraQuick say the test would provide a new and powerful attack against the American HIV epidemic.
Art Caplan, a regular guest on The Takeaway, discusses whether this test kit is a game-changer in the fight against HIV/AIDS and whether the kit’s benefits outweigh the ethical holes facing home-testing. Caplan is a professor of bioethics at the University of Pennsylvania.
The World is an independent newsroom. We’re not funded by billionaires; instead, we rely on readers and listeners like you. As a listener, you’re a crucial part of our team and our global community. Your support is vital to running our nonprofit newsroom, and we can’t do this work without you. Will you support The World with a gift today? Donations made between now and Dec. 31 will be matched 1:1. Thanks for investing in our work!